NAFDAC Approves Production Of Chloroquine For Clinical Trial Against Coronavirus

The National Agency for Food and Drug Administration and Control (NAFDAC) has approved the production of Chloroquine for clinical trials in the search for a cure for COVID-19. Director-General of the agency, Mojisola Adeyeye, made the announcement on Friday at the NAFDAC headquarters in Lagos.She, however, pointed out that NAFDAC is not approving Chloroquine for the treatment of via IFTTT